Guided Therapeutics (GTHP) Gross Margin Growth (1y) (2013 - 2025)
Guided Therapeutics (GTHP) Gross Margin Growth (1y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 128.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 448.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 305.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -6.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 391.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 153.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -4,158.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 69.00 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27,763.00 |
| Dec 31, 2024 | -25,000.00 |
| Mar 31, 2024 | 758.00 |
| Jun 30, 2023 | -5,500.00 |
| Mar 31, 2023 | -2,091.00 |
| Sep 30, 2022 | 22,105.00 |
| Jun 30, 2022 | -2,000.00 |
| Dec 31, 2021 | -27,167.00 |
| Sep 30, 2021 | -20,547.00 |
| Dec 31, 2020 | 26,500.00 |
| Sep 30, 2020 | -1,558.00 |
| Dec 31, 2019 | 17,976.00 |
| Sep 30, 2019 | 0.00 |
| Jun 30, 2019 | -648,750.00 |
| Mar 31, 2019 | 6,944.00 |
| Dec 31, 2018 | 10,832.00 |
| Sep 30, 2018 | 29,394.00 |
| Jun 30, 2018 | 8,175.00 |
| Mar 31, 2018 | 119.00 |
| Dec 31, 2017 | -25,197.00 |